Bio-Rad Laboratories Inc - Class A
Research Bio-Rad Laboratories Inc - Class A (BIO) on Bullrun: market cap USD 10.44B, P/E 47.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBIO
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 10.44B
- P/E47.3
- Financial periodQ2 2026
- RevenueUSD 651.00M
- Net incomeUSD 371.40M
- Free cash flowUSD 66.70M
- Gross margin53.1%
Valuation Snapshot
latest market cap is USD 10.44B; P/E is 47.3.
Peer valuation comparison
Latest P/E is 47.29x versus a Healthcare sector median of 24.46x (93.3% above).
Latest P/E is 47.29x versus a United States median of 24.87x (90.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 2.58B | USD 759.90M | USD 374.60M | 51.9% | 27.85 | USD 529.80M | USD 1.20B | USD 7.45B |
| FY2024 | USD 2.57B | -USD 1.84B | USD 289.60M | 53.7% | -65.36 | USD 488.10M | USD 1.20B | USD 6.57B |
| FY2023 | USD 2.67B | -USD 637.30M | USD 218.20M | 53.4% | -21.82 | USD 403.80M | USD 1.20B | USD 8.74B |
| FY2022 | USD 2.80B | -USD 3.63B | USD 81.60M | 55.9% | -121.79 | USD 434.20M | USD 1.20B | USD 9.62B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 10.44B | 47.3 | n/a | n/a |
| 2025 | 2025-12-31 | USD 8.18B | 10.9 | n/a | n/a |
| 2024 | 2024-12-31 | USD 9.20B | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 9.41B | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 12.54B | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 22.62B | 5.4 | n/a | n/a |
About Bio-Rad Laboratories Inc - Class A
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Bio-Rad Laboratories Inc - Class A's market cap?
Bio-Rad Laboratories Inc - Class A's market capitalization is USD 10.44B.
What is Bio-Rad Laboratories Inc - Class A's P/E ratio?
Bio-Rad Laboratories Inc - Class A's price-to-earnings (P/E) ratio is 47.3.
What does Bio-Rad Laboratories Inc - Class A do?
Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.